Open AccessCan Ischemia Modified Albumin (IMA) Levels Be a Predictor of Acute Pancreatitis?
Author(s) -
Hakan Yarkıcı,
Gözde Derviş Hakim,
Elif Merve Arı,
Harun Akar,
Ayfer Çolak
Publication year - 2021
Publication title -
the turkish journal of gastroenterology/the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2021.191054
Subject(s) - medicine , acute pancreatitis , procalcitonin , etiology , pancreatitis , gastroenterology , disease , hematocrit , context (archaeology) , biliary disease , severity of illness , sepsis , paleontology , biology
We aimed to evaluate the value of ischemia modified albumin (IMA) as a prognostic marker in acute pancreatitis (AP) patients, determine whether it is efficient in assessing the disease severity or not, and to estimate the correlation between IMA and the inflammatory markers, prognostic markers and scoring systems routinely used in clinical practice.